Oncternal Therapeutics, Inc. (ONCT)
NASDAQ: ONCT · Real-Time Price · USD
1.120
-0.020 (-1.75%)
Nov 21, 2024, 10:44 AM EST - Market open
Oncternal Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 32 | 56 | 112 | 239 | 61 | |
| Market Cap Growth | -77.92% | -43.88% | -49.79% | -53.05% | 293.15% | - | |
| Enterprise Value | -11 | -8 | -14 | 15 | 218 | 38 | |
| Last Close Price | 1.14 | 10.72 | 20.00 | 45.40 | 98.00 | 79.00 | |
| PS Ratio | 1.56 | 40.28 | 37.81 | 26.00 | 70.80 | 25.06 | |
| PB Ratio | 0.37 | 1.05 | 0.92 | 1.27 | 2.12 | 4.25 | |
| P/TBV Ratio | 0.43 | 1.05 | 0.92 | 1.27 | 2.12 | 4.25 | |
| EV/Sales Ratio | - | - | - | 3.46 | 64.62 | 15.63 | |
| Debt / Equity Ratio | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | |
| Asset Turnover | 0.07 | 0.01 | 0.02 | 0.04 | 0.05 | 0.11 | |
| Quick Ratio | 2.31 | 6.71 | 8.32 | 16.78 | 19.93 | 2.73 | |
| Current Ratio | 2.39 | 6.94 | 8.76 | 16.99 | 20.14 | 2.83 | |
| Return on Equity (ROE) | -149.86% | -86.75% | -59.25% | -31.17% | -27.07% | -214.06% | |
| Return on Assets (ROA) | -74.11% | -49.48% | -34.63% | -18.46% | -15.60% | -42.96% | |
| Return on Capital (ROIC) | -93.35% | -57.03% | -37.64% | -19.49% | -17.20% | -58.43% | |
| Earnings Yield | -1024.75% | -124.86% | -78.40% | -27.93% | -7.21% | -56.25% | |
| FCF Yield | -789.33% | -101.72% | -65.15% | -23.70% | -7.32% | -27.55% | |
| Buyback Yield / Dilution | -1.60% | -11.79% | -6.65% | -142.90% | -96.58% | -187.64% | |
| Total Shareholder Return | -1.60% | -11.79% | -6.65% | -142.90% | -96.58% | -187.64% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.